• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

CTT Systems: Better Q2 and OK FY'26 guidance on OEM+AM - ABG

CTTThird party research21.07.2026 klo 09.55
Discuss

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Better organic growth (-4% vs. ABG -10%)
* Next phase of OEM ramp-up Q1'27, AM back to y-o-y growth
* Share -6% into numbers, trades at 21-11x EBIT '26e-'27e (pre-Q2)

Q2 details
Sales were 11% above our expectations, with sales of SEK 76m down 4% y-o-y organically (ABGSCe -10%). This was driven by a 15% reported decline in aftermarket sales (ABG -30% y-o-y), while system sales grew 20% y-o-y (ABG +26%). AM share of sales was 64% (ABG 58%). According to the CEO, growth in system sales was driven by ramp-up in aircraft production rates and increased content value per aircraft. Sales to the private jet segment was low, and below expectations. EBIT declined ~20% y-o-y to SEK 14m (ABG 13m), as the margin came in at 19% (ABG 19%, 25% Q2'25). Free cash flow of 18m was strong (+2m last year).

Outlook and estimate changes
For Q3, the CEO expects net sales (in USD terms) "modestly below Q2'26", where we have (in SEK terms) Q3 sales of SEK 78m vs. the Q2 outcome of 76m. For FY'26, the outlook (in USD terms) is for similar H2'26 OEM sales as in H1'26 as the next ramp-up in production volumes is scheduled for Q1'27, where we have (in SEK terms) H2'26 sales of SEK 43m vs. H1'26 outcome of 38m. The guidance for AM sales is for 5-15% organic growth FY'26 (we currently forecast +14%). For Retrofit, FY'26 revenue is expected to be flat vs. FY'25 (we have SEK 5m vs. ~3m FY'25). Finally, Private jet projects have been postponed, so management now expects "the weakest year in several years", before expecting a "very strong recovery next year". We currently have SEK 25m in FY'26 sales vs. the L5Y average of ~19m. All in all, we believe that the Q3 deviation on EBIT and our impression of the H2'26+FY'26 guidance vs. ABGSCe would mechanically lower our FY'26e EBIT by 5-10%. However, using current FX rates vs. our latest published note, we note that the USD/SEK would raise sales by 2%, with a greater impact on EBIT (which could have a 2-3x impact on EBIT vs. sales).

Final thoughts
A better-than-expected Q2 report where it was encouraging to hear OEM and AM guidance relatively in-line with expectations, despite the more cautious view on Private jet deliveries. The share has returned -6% L1M, below the broader market (OMXSGI +1%), and trades at (pre-Q2 estimates) 21-11x EBIT '26e-'27e (20x L10Y). There is a conference call at 09:30 CET, link.

pagebreak